averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
BPTF
|
ENSG00000171634.12 | bromodomain PHD finger transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BPTF | hg19_v2_chr17_+_65821780_65821826 | 0.61 | 1.5e-23 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_216176540 | 75.19 |
ENST00000236959.9
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
chr3_+_127323739 | 64.79 |
ENST00000491422.1
|
MCM2
|
minichromosome maintenance complex component 2 |
chr14_-_55658323 | 64.15 |
ENST00000554067.1
ENST00000247191.2 |
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5 |
chr17_+_4699439 | 63.99 |
ENST00000270586.3
|
PSMB6
|
proteasome (prosome, macropain) subunit, beta type, 6 |
chr1_-_150207017 | 54.50 |
ENST00000369119.3
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
chr6_+_34725263 | 53.22 |
ENST00000374018.1
ENST00000374017.3 |
SNRPC
|
small nuclear ribonucleoprotein polypeptide C |
chr2_+_216176761 | 52.90 |
ENST00000540518.1
ENST00000435675.1 |
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
chr14_+_56127989 | 52.01 |
ENST00000555573.1
|
KTN1
|
kinectin 1 (kinesin receptor) |
chr9_+_75766652 | 49.53 |
ENST00000257497.6
|
ANXA1
|
annexin A1 |
chr7_+_56019486 | 47.62 |
ENST00000446692.1
ENST00000285298.4 ENST00000443449.1 |
GBAS
MRPS17
|
glioblastoma amplified sequence mitochondrial ribosomal protein S17 |
chr12_+_16064258 | 46.28 |
ENST00000524480.1
ENST00000531803.1 ENST00000532964.1 |
DERA
|
deoxyribose-phosphate aldolase (putative) |
chr14_+_73563735 | 44.43 |
ENST00000532192.1
|
RBM25
|
RNA binding motif protein 25 |
chr5_+_159848854 | 43.42 |
ENST00000517480.1
ENST00000520452.1 ENST00000393964.1 |
PTTG1
|
pituitary tumor-transforming 1 |
chr7_+_141438118 | 43.07 |
ENST00000265304.6
ENST00000498107.1 ENST00000467681.1 ENST00000465582.1 ENST00000463093.1 |
SSBP1
|
single-stranded DNA binding protein 1, mitochondrial |
chr1_+_45212074 | 42.27 |
ENST00000372217.1
|
KIF2C
|
kinesin family member 2C |
chr5_+_172385732 | 42.27 |
ENST00000519974.1
ENST00000521476.1 |
RPL26L1
|
ribosomal protein L26-like 1 |
chr3_+_171757346 | 41.86 |
ENST00000421757.1
ENST00000415807.2 ENST00000392699.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
chr5_+_74011328 | 41.73 |
ENST00000513336.1
|
HEXB
|
hexosaminidase B (beta polypeptide) |
chr16_+_3068393 | 41.57 |
ENST00000573001.1
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
chr4_-_84035905 | 41.31 |
ENST00000311507.4
|
PLAC8
|
placenta-specific 8 |
chr4_+_57845024 | 40.50 |
ENST00000431623.2
ENST00000441246.2 |
POLR2B
|
polymerase (RNA) II (DNA directed) polypeptide B, 140kDa |
chr6_+_24775153 | 40.32 |
ENST00000356509.3
ENST00000230056.3 |
GMNN
|
geminin, DNA replication inhibitor |
chr14_-_55658252 | 38.80 |
ENST00000395425.2
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5 |
chr2_+_102456277 | 38.68 |
ENST00000421882.1
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
chr9_+_42671887 | 38.33 |
ENST00000456520.1
ENST00000377391.3 |
CBWD7
|
COBW domain containing 7 |
chr13_-_37679803 | 37.50 |
ENST00000379800.3
|
CSNK1A1L
|
casein kinase 1, alpha 1-like |
chr22_-_42336209 | 37.26 |
ENST00000472374.2
|
CENPM
|
centromere protein M |
chr4_+_57845043 | 36.95 |
ENST00000433463.1
ENST00000314595.5 |
POLR2B
|
polymerase (RNA) II (DNA directed) polypeptide B, 140kDa |
chr4_-_84035868 | 36.75 |
ENST00000426923.2
ENST00000509973.1 |
PLAC8
|
placenta-specific 8 |
chr5_+_162932554 | 36.68 |
ENST00000321757.6
ENST00000421814.2 ENST00000518095.1 |
MAT2B
|
methionine adenosyltransferase II, beta |
chrX_+_102611373 | 36.31 |
ENST00000372661.3
ENST00000372656.3 |
WBP5
|
WW domain binding protein 5 |
chr5_-_34919094 | 35.96 |
ENST00000341754.4
|
RAD1
|
RAD1 homolog (S. pombe) |
chr6_-_8102279 | 35.42 |
ENST00000488226.2
|
EEF1E1
|
eukaryotic translation elongation factor 1 epsilon 1 |
chr1_+_165864800 | 35.00 |
ENST00000469256.2
|
UCK2
|
uridine-cytidine kinase 2 |
chr19_-_29704448 | 34.93 |
ENST00000304863.4
|
UQCRFS1
|
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
chr20_+_3776371 | 34.63 |
ENST00000245960.5
|
CDC25B
|
cell division cycle 25B |
chr6_+_34725181 | 34.28 |
ENST00000244520.5
|
SNRPC
|
small nuclear ribonucleoprotein polypeptide C |
chr9_-_86593238 | 34.23 |
ENST00000351839.3
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K |
chr2_+_171785012 | 34.22 |
ENST00000234160.4
|
GORASP2
|
golgi reassembly stacking protein 2, 55kDa |
chr4_-_71705027 | 34.21 |
ENST00000545193.1
|
GRSF1
|
G-rich RNA sequence binding factor 1 |
chr2_-_225434538 | 33.76 |
ENST00000409096.1
|
CUL3
|
cullin 3 |
chr4_-_71705060 | 33.75 |
ENST00000514161.1
|
GRSF1
|
G-rich RNA sequence binding factor 1 |
chr16_-_58585513 | 33.62 |
ENST00000245138.4
ENST00000567285.1 |
CNOT1
|
CCR4-NOT transcription complex, subunit 1 |
chr5_+_159848807 | 32.31 |
ENST00000352433.5
|
PTTG1
|
pituitary tumor-transforming 1 |
chr19_+_52932435 | 32.24 |
ENST00000301085.4
|
ZNF534
|
zinc finger protein 534 |
chr1_+_148739443 | 32.20 |
ENST00000417839.1
|
NBPF16
|
neuroblastoma breakpoint family, member 16 |
chr13_-_31039375 | 31.94 |
ENST00000399494.1
|
HMGB1
|
high mobility group box 1 |
chr10_+_115438920 | 31.58 |
ENST00000429617.1
ENST00000369331.4 |
CASP7
|
caspase 7, apoptosis-related cysteine peptidase |
chr5_+_167913450 | 31.51 |
ENST00000231572.3
ENST00000538719.1 |
RARS
|
arginyl-tRNA synthetase |
chr7_+_141438393 | 31.30 |
ENST00000484178.1
ENST00000473783.1 ENST00000481508.1 |
SSBP1
|
single-stranded DNA binding protein 1, mitochondrial |
chr12_-_110888103 | 31.08 |
ENST00000426440.1
ENST00000228825.7 |
ARPC3
|
actin related protein 2/3 complex, subunit 3, 21kDa |
chr1_+_165864821 | 30.49 |
ENST00000470820.1
|
UCK2
|
uridine-cytidine kinase 2 |
chr1_+_45212051 | 30.35 |
ENST00000372222.3
|
KIF2C
|
kinesin family member 2C |
chr19_+_54619125 | 30.30 |
ENST00000445811.1
ENST00000419967.1 ENST00000445124.1 ENST00000447810.1 |
PRPF31
|
pre-mRNA processing factor 31 |
chr17_+_17082842 | 30.15 |
ENST00000579361.1
|
MPRIP
|
myosin phosphatase Rho interacting protein |
chr1_+_93297622 | 30.14 |
ENST00000315741.5
|
RPL5
|
ribosomal protein L5 |
chrX_+_49028265 | 30.12 |
ENST00000376322.3
ENST00000376327.5 |
PLP2
|
proteolipid protein 2 (colonic epithelium-enriched) |
chr14_+_55590646 | 29.49 |
ENST00000553493.1
|
LGALS3
|
lectin, galactoside-binding, soluble, 3 |
chr17_-_46178741 | 29.47 |
ENST00000581003.1
ENST00000225603.4 |
CBX1
|
chromobox homolog 1 |
chr5_+_162930114 | 29.46 |
ENST00000280969.5
|
MAT2B
|
methionine adenosyltransferase II, beta |
chr1_-_6260896 | 29.41 |
ENST00000497965.1
|
RPL22
|
ribosomal protein L22 |
chr5_+_82767583 | 28.85 |
ENST00000512590.2
ENST00000513960.1 ENST00000513984.1 ENST00000502527.2 |
VCAN
|
versican |
chr2_+_187371440 | 28.73 |
ENST00000445547.1
|
ZC3H15
|
zinc finger CCCH-type containing 15 |
chr7_-_99699538 | 28.72 |
ENST00000343023.6
ENST00000303887.5 |
MCM7
|
minichromosome maintenance complex component 7 |
chr6_+_119215308 | 28.48 |
ENST00000229595.5
|
ASF1A
|
anti-silencing function 1A histone chaperone |
chr2_-_151344172 | 28.45 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
chr14_+_54863682 | 28.41 |
ENST00000543789.2
ENST00000442975.2 ENST00000458126.2 ENST00000556102.2 |
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
chr19_+_10362577 | 28.37 |
ENST00000592514.1
ENST00000307422.5 ENST00000253099.6 ENST00000590150.1 ENST00000590669.1 |
MRPL4
|
mitochondrial ribosomal protein L4 |
chr5_-_133510456 | 28.33 |
ENST00000520417.1
|
SKP1
|
S-phase kinase-associated protein 1 |
chr1_+_203830703 | 28.13 |
ENST00000414487.2
|
SNRPE
|
small nuclear ribonucleoprotein polypeptide E |
chr5_-_68665815 | 28.11 |
ENST00000380818.3
ENST00000328663.4 |
TAF9
|
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa |
chr1_-_54405773 | 27.98 |
ENST00000371376.1
|
HSPB11
|
heat shock protein family B (small), member 11 |
chr7_+_55433131 | 27.91 |
ENST00000254770.2
|
LANCL2
|
LanC lantibiotic synthetase component C-like 2 (bacterial) |
chr1_-_193075180 | 27.90 |
ENST00000367440.3
|
GLRX2
|
glutaredoxin 2 |
chr12_+_16064106 | 27.68 |
ENST00000428559.2
|
DERA
|
deoxyribose-phosphate aldolase (putative) |
chr18_-_33702078 | 27.59 |
ENST00000586829.1
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6 |
chr11_-_88070920 | 27.11 |
ENST00000524463.1
ENST00000227266.5 |
CTSC
|
cathepsin C |
chr14_+_102276209 | 26.98 |
ENST00000445439.3
ENST00000334743.5 ENST00000557095.1 |
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma |
chr22_-_42086477 | 26.76 |
ENST00000402458.1
|
NHP2L1
|
NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) |
chr7_-_144435985 | 26.69 |
ENST00000549981.1
|
TPK1
|
thiamin pyrophosphokinase 1 |
chr5_+_68462837 | 26.21 |
ENST00000256442.5
|
CCNB1
|
cyclin B1 |
chr19_+_6361754 | 26.15 |
ENST00000597326.1
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
chrX_+_24072833 | 26.10 |
ENST00000253039.4
|
EIF2S3
|
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa |
chr12_-_102455846 | 26.09 |
ENST00000545679.1
|
CCDC53
|
coiled-coil domain containing 53 |
chr17_+_66243715 | 25.87 |
ENST00000359904.3
|
AMZ2
|
archaelysin family metallopeptidase 2 |
chr3_+_183892635 | 25.74 |
ENST00000427072.1
ENST00000411763.2 ENST00000292807.5 ENST00000448139.1 ENST00000455925.1 |
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit |
chr3_-_130465604 | 25.72 |
ENST00000356763.3
|
PIK3R4
|
phosphoinositide-3-kinase, regulatory subunit 4 |
chr7_-_105162652 | 25.69 |
ENST00000356362.2
ENST00000469408.1 |
PUS7
|
pseudouridylate synthase 7 homolog (S. cerevisiae) |
chr5_+_65222384 | 25.65 |
ENST00000380943.2
ENST00000416865.2 ENST00000380939.2 ENST00000380936.1 ENST00000380935.1 |
ERBB2IP
|
erbb2 interacting protein |
chr7_-_87856280 | 25.57 |
ENST00000490437.1
ENST00000431660.1 |
SRI
|
sorcin |
chr12_-_57146095 | 25.27 |
ENST00000550770.1
ENST00000338193.6 |
PRIM1
|
primase, DNA, polypeptide 1 (49kDa) |
chr12_+_118454500 | 25.25 |
ENST00000537315.1
ENST00000229043.3 ENST00000484086.2 ENST00000420967.1 ENST00000454402.2 ENST00000392542.2 ENST00000535092.1 |
RFC5
|
replication factor C (activator 1) 5, 36.5kDa |
chr1_-_19426149 | 25.22 |
ENST00000429347.2
|
UBR4
|
ubiquitin protein ligase E3 component n-recognin 4 |
chr11_-_62439012 | 25.06 |
ENST00000532208.1
ENST00000377954.2 ENST00000415855.2 ENST00000431002.2 ENST00000354588.3 |
C11orf48
|
chromosome 11 open reading frame 48 |
chr4_+_57843876 | 24.99 |
ENST00000450656.1
ENST00000381227.1 |
POLR2B
|
polymerase (RNA) II (DNA directed) polypeptide B, 140kDa |
chr2_+_201170770 | 24.98 |
ENST00000409988.3
ENST00000409385.1 |
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
chr17_+_45728427 | 24.88 |
ENST00000540627.1
|
KPNB1
|
karyopherin (importin) beta 1 |
chr19_-_46195029 | 24.74 |
ENST00000588599.1
ENST00000585392.1 ENST00000590212.1 ENST00000587367.1 ENST00000391932.3 |
SNRPD2
|
small nuclear ribonucleoprotein D2 polypeptide 16.5kDa |
chr1_-_154580616 | 24.72 |
ENST00000368474.4
|
ADAR
|
adenosine deaminase, RNA-specific |
chr18_+_3451584 | 24.71 |
ENST00000551541.1
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr2_-_197664366 | 24.67 |
ENST00000409364.3
ENST00000263956.3 |
GTF3C3
|
general transcription factor IIIC, polypeptide 3, 102kDa |
chr7_-_87856303 | 24.65 |
ENST00000394641.3
|
SRI
|
sorcin |
chr3_-_81792780 | 24.61 |
ENST00000489715.1
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1 |
chr10_+_51371390 | 24.52 |
ENST00000478381.1
ENST00000451577.2 ENST00000374098.2 ENST00000374097.2 |
TIMM23B
|
translocase of inner mitochondrial membrane 23 homolog B (yeast) |
chr19_-_47349395 | 24.44 |
ENST00000597020.1
|
AP2S1
|
adaptor-related protein complex 2, sigma 1 subunit |
chr10_+_13652047 | 24.39 |
ENST00000601460.1
|
RP11-295P9.3
|
Uncharacterized protein |
chr11_+_101983176 | 24.29 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
chr17_+_66521936 | 24.08 |
ENST00000592800.1
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
chr7_-_6865826 | 24.05 |
ENST00000538180.1
|
CCZ1B
|
CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae) |
chr15_+_41624892 | 23.92 |
ENST00000260359.6
ENST00000450318.1 ENST00000450592.2 ENST00000559596.1 ENST00000414849.2 ENST00000560747.1 ENST00000560177.1 |
NUSAP1
|
nucleolar and spindle associated protein 1 |
chr1_-_115124257 | 23.40 |
ENST00000369541.3
|
BCAS2
|
breast carcinoma amplified sequence 2 |
chr15_+_89787180 | 23.34 |
ENST00000300027.8
ENST00000310775.7 ENST00000567891.1 ENST00000564920.1 ENST00000565255.1 ENST00000567996.1 ENST00000451393.2 ENST00000563250.1 |
FANCI
|
Fanconi anemia, complementation group I |
chr2_-_169769787 | 23.24 |
ENST00000451987.1
|
SPC25
|
SPC25, NDC80 kinetochore complex component |
chr7_+_64838712 | 23.15 |
ENST00000328747.7
ENST00000431504.1 ENST00000357512.2 |
ZNF92
|
zinc finger protein 92 |
chr13_-_37573432 | 23.11 |
ENST00000413537.2
ENST00000443765.1 ENST00000239891.3 |
ALG5
|
ALG5, dolichyl-phosphate beta-glucosyltransferase |
chr22_+_40742512 | 23.09 |
ENST00000454266.2
ENST00000342312.6 |
ADSL
|
adenylosuccinate lyase |
chrX_+_119737806 | 23.09 |
ENST00000371317.5
|
MCTS1
|
malignant T cell amplified sequence 1 |
chr20_-_5107180 | 23.03 |
ENST00000379160.3
|
PCNA
|
proliferating cell nuclear antigen |
chr7_+_64838786 | 22.93 |
ENST00000450302.2
|
ZNF92
|
zinc finger protein 92 |
chr5_+_10250328 | 22.84 |
ENST00000515390.1
|
CCT5
|
chaperonin containing TCP1, subunit 5 (epsilon) |
chr19_-_40331345 | 22.75 |
ENST00000597224.1
|
FBL
|
fibrillarin |
chr22_+_40742497 | 22.73 |
ENST00000216194.7
|
ADSL
|
adenylosuccinate lyase |
chr3_-_52569023 | 22.62 |
ENST00000307076.4
|
NT5DC2
|
5'-nucleotidase domain containing 2 |
chr5_-_54603368 | 22.54 |
ENST00000508346.1
ENST00000251636.5 |
DHX29
|
DEAH (Asp-Glu-Ala-His) box polypeptide 29 |
chr18_+_9103957 | 22.48 |
ENST00000400033.1
|
NDUFV2
|
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa |
chr2_+_201170596 | 22.42 |
ENST00000439084.1
ENST00000409718.1 |
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
chr15_+_65843130 | 22.41 |
ENST00000569894.1
|
PTPLAD1
|
protein tyrosine phosphatase-like A domain containing 1 |
chr6_-_150067632 | 22.40 |
ENST00000460354.2
ENST00000367404.4 ENST00000543637.1 |
NUP43
|
nucleoporin 43kDa |
chr15_-_76603727 | 22.40 |
ENST00000560595.1
ENST00000433983.2 ENST00000559386.1 ENST00000559602.1 ENST00000560726.1 ENST00000557943.1 |
ETFA
|
electron-transfer-flavoprotein, alpha polypeptide |
chr15_+_59397275 | 22.31 |
ENST00000288207.2
|
CCNB2
|
cyclin B2 |
chr14_+_54863739 | 22.29 |
ENST00000541304.1
|
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
chr3_+_172468505 | 22.26 |
ENST00000427830.1
ENST00000417960.1 ENST00000428567.1 ENST00000366090.2 ENST00000426894.1 |
ECT2
|
epithelial cell transforming sequence 2 oncogene |
chr6_-_150067696 | 22.23 |
ENST00000340413.2
ENST00000367403.3 |
NUP43
|
nucleoporin 43kDa |
chr7_+_76054224 | 22.22 |
ENST00000394857.3
|
ZP3
|
zona pellucida glycoprotein 3 (sperm receptor) |
chr2_+_160590469 | 22.14 |
ENST00000409591.1
|
MARCH7
|
membrane-associated ring finger (C3HC4) 7, E3 ubiquitin protein ligase |
chr16_+_85832146 | 22.08 |
ENST00000565078.1
|
COX4I1
|
cytochrome c oxidase subunit IV isoform 1 |
chr2_-_150444116 | 22.06 |
ENST00000428879.1
ENST00000422782.2 |
MMADHC
|
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria |
chr3_+_184018352 | 22.02 |
ENST00000435761.1
ENST00000439383.1 |
PSMD2
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 |
chr1_-_150208412 | 21.99 |
ENST00000532744.1
ENST00000369114.5 ENST00000369115.2 ENST00000369116.4 |
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
chr7_+_5938351 | 21.91 |
ENST00000325974.6
|
CCZ1
|
CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae) |
chr17_+_18601299 | 21.89 |
ENST00000572555.1
ENST00000395902.3 ENST00000449552.2 |
TRIM16L
|
tripartite motif containing 16-like |
chr17_-_40134339 | 21.87 |
ENST00000587727.1
|
DNAJC7
|
DnaJ (Hsp40) homolog, subfamily C, member 7 |
chr11_-_58343319 | 21.82 |
ENST00000395074.2
|
LPXN
|
leupaxin |
chr17_+_66245341 | 21.81 |
ENST00000577985.1
|
AMZ2
|
archaelysin family metallopeptidase 2 |
chr12_+_93861282 | 21.79 |
ENST00000552217.1
ENST00000393128.4 ENST00000547098.1 |
MRPL42
|
mitochondrial ribosomal protein L42 |
chr5_+_65222299 | 21.74 |
ENST00000284037.5
|
ERBB2IP
|
erbb2 interacting protein |
chr1_-_45452240 | 21.69 |
ENST00000372183.3
ENST00000372182.4 ENST00000360403.2 |
EIF2B3
|
eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa |
chr2_+_86426478 | 21.69 |
ENST00000254644.8
ENST00000605125.1 ENST00000337109.4 ENST00000409180.1 |
MRPL35
|
mitochondrial ribosomal protein L35 |
chr1_+_165797024 | 21.69 |
ENST00000372212.4
|
UCK2
|
uridine-cytidine kinase 2 |
chr14_+_56078695 | 21.66 |
ENST00000416613.1
|
KTN1
|
kinectin 1 (kinesin receptor) |
chr1_+_93297582 | 21.56 |
ENST00000370321.3
|
RPL5
|
ribosomal protein L5 |
chr18_+_20513782 | 21.50 |
ENST00000399722.2
ENST00000399725.2 ENST00000399721.2 ENST00000583594.1 |
RBBP8
|
retinoblastoma binding protein 8 |
chr6_+_63921399 | 21.45 |
ENST00000356170.3
|
FKBP1C
|
FK506 binding protein 1C |
chr3_+_172468472 | 21.44 |
ENST00000232458.5
ENST00000392692.3 |
ECT2
|
epithelial cell transforming sequence 2 oncogene |
chr16_-_84651673 | 21.43 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chr2_-_85641162 | 21.26 |
ENST00000447219.2
ENST00000409670.1 ENST00000409724.1 |
CAPG
|
capping protein (actin filament), gelsolin-like |
chr19_+_47634039 | 21.21 |
ENST00000597808.1
ENST00000413379.3 ENST00000600706.1 ENST00000540850.1 ENST00000598840.1 ENST00000600753.1 ENST00000270225.7 ENST00000392776.3 |
SAE1
|
SUMO1 activating enzyme subunit 1 |
chr6_-_31508304 | 21.18 |
ENST00000376177.2
|
DDX39B
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B |
chr1_+_223889285 | 21.15 |
ENST00000433674.2
|
CAPN2
|
calpain 2, (m/II) large subunit |
chr5_-_133968529 | 21.10 |
ENST00000402673.2
|
SAR1B
|
SAR1 homolog B (S. cerevisiae) |
chr16_-_84651647 | 21.06 |
ENST00000564057.1
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chr12_-_76477707 | 20.83 |
ENST00000551992.1
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr11_-_62609281 | 20.81 |
ENST00000525239.1
ENST00000538098.2 |
WDR74
|
WD repeat domain 74 |
chr2_-_136678123 | 20.78 |
ENST00000422708.1
|
DARS
|
aspartyl-tRNA synthetase |
chr12_+_75874984 | 20.77 |
ENST00000550491.1
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr3_-_72496035 | 20.74 |
ENST00000477973.2
|
RYBP
|
RING1 and YY1 binding protein |
chr17_+_57287228 | 20.73 |
ENST00000578922.1
ENST00000300917.5 |
SMG8
|
SMG8 nonsense mediated mRNA decay factor |
chr22_+_41258250 | 20.66 |
ENST00000544094.1
|
XPNPEP3
|
X-prolyl aminopeptidase (aminopeptidase P) 3, putative |
chr1_-_148346929 | 20.66 |
ENST00000414710.2
ENST00000369188.3 ENST00000369202.1 |
NBPF20
|
neuroblastoma breakpoint family, member 20 |
chr18_+_3447572 | 20.60 |
ENST00000548489.2
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr1_-_11115877 | 20.59 |
ENST00000490101.1
|
SRM
|
spermidine synthase |
chr7_+_100303676 | 20.54 |
ENST00000303151.4
|
POP7
|
processing of precursor 7, ribonuclease P/MRP subunit (S. cerevisiae) |
chr12_-_110883346 | 20.52 |
ENST00000547365.1
|
ARPC3
|
actin related protein 2/3 complex, subunit 3, 21kDa |
chr14_+_54863667 | 20.51 |
ENST00000335183.6
|
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
chr12_+_75874580 | 20.49 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr15_-_78592053 | 20.44 |
ENST00000267973.2
|
WDR61
|
WD repeat domain 61 |
chrX_-_102943022 | 20.32 |
ENST00000433176.2
|
MORF4L2
|
mortality factor 4 like 2 |
chr15_-_63450192 | 20.27 |
ENST00000411926.1
|
RPS27L
|
ribosomal protein S27-like |
chr5_-_142780280 | 20.19 |
ENST00000424646.2
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr3_+_42632298 | 20.19 |
ENST00000011691.4
|
SS18L2
|
synovial sarcoma translocation gene on chromosome 18-like 2 |
chr14_-_58894223 | 20.17 |
ENST00000555593.1
|
TIMM9
|
translocase of inner mitochondrial membrane 9 homolog (yeast) |
chr2_-_62115725 | 20.12 |
ENST00000538252.1
ENST00000544079.1 ENST00000394440.3 |
CCT4
|
chaperonin containing TCP1, subunit 4 (delta) |
chr4_-_99850243 | 20.08 |
ENST00000280892.6
ENST00000511644.1 ENST00000504432.1 ENST00000505992.1 |
EIF4E
|
eukaryotic translation initiation factor 4E |
chr8_+_29952914 | 19.93 |
ENST00000321250.8
ENST00000518001.1 ENST00000520682.1 ENST00000442880.2 ENST00000523116.1 |
LEPROTL1
|
leptin receptor overlapping transcript-like 1 |
chr9_-_35080013 | 19.90 |
ENST00000378643.3
|
FANCG
|
Fanconi anemia, complementation group G |
chrX_+_118708493 | 19.87 |
ENST00000371558.2
|
UBE2A
|
ubiquitin-conjugating enzyme E2A |
chr12_-_112847354 | 19.86 |
ENST00000550566.2
ENST00000553213.2 ENST00000424576.2 ENST00000202773.9 |
RPL6
|
ribosomal protein L6 |
chr9_-_36276966 | 19.79 |
ENST00000543356.2
ENST00000396594.3 |
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
chr10_+_47894023 | 19.77 |
ENST00000358474.5
|
FAM21B
|
family with sequence similarity 21, member B |
chr6_+_26104104 | 19.75 |
ENST00000377803.2
|
HIST1H4C
|
histone cluster 1, H4c |
chrX_-_20236970 | 19.63 |
ENST00000379548.4
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
chr17_-_40288449 | 19.62 |
ENST00000552162.1
ENST00000550504.1 |
RAB5C
|
RAB5C, member RAS oncogene family |
chr6_-_30712313 | 19.60 |
ENST00000376377.2
ENST00000259874.5 |
IER3
|
immediate early response 3 |
chr1_-_153538292 | 19.57 |
ENST00000497140.1
ENST00000368708.3 |
S100A2
|
S100 calcium binding protein A2 |
chr16_-_23607598 | 19.56 |
ENST00000562133.1
ENST00000570319.1 ENST00000007516.3 |
NDUFAB1
|
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa |
chr1_+_145289772 | 19.53 |
ENST00000369339.3
|
NBPF10
|
neuroblastoma breakpoint family, member 10 |
chr4_-_103746924 | 19.52 |
ENST00000505207.1
ENST00000502404.1 ENST00000507845.1 |
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr19_+_33865218 | 19.41 |
ENST00000585933.2
|
CEBPG
|
CCAAT/enhancer binding protein (C/EBP), gamma |
chr2_-_62115659 | 19.27 |
ENST00000544185.1
|
CCT4
|
chaperonin containing TCP1, subunit 4 (delta) |
chr3_-_49066811 | 19.26 |
ENST00000442157.1
ENST00000326739.4 |
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
32.0 | 128.1 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
21.8 | 87.2 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
21.3 | 127.8 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
19.6 | 19.6 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
16.5 | 66.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
16.5 | 49.5 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
15.3 | 45.8 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
14.6 | 87.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
12.9 | 51.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
12.5 | 49.8 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
12.4 | 37.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
10.5 | 31.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
9.7 | 87.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
9.5 | 94.9 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
9.4 | 93.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
9.3 | 27.9 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) mitochondrial membrane fission(GO:0090149) |
9.2 | 55.3 | GO:0048254 | snoRNA localization(GO:0048254) |
9.0 | 36.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
8.9 | 26.7 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
8.9 | 26.7 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
8.8 | 61.8 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
8.7 | 26.2 | GO:2000775 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
8.6 | 34.2 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
8.6 | 25.7 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
8.4 | 33.8 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
8.4 | 25.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
8.3 | 41.7 | GO:0007619 | courtship behavior(GO:0007619) |
8.2 | 24.7 | GO:1900369 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
7.7 | 23.1 | GO:0002188 | translation reinitiation(GO:0002188) |
7.7 | 23.0 | GO:0006272 | leading strand elongation(GO:0006272) |
7.6 | 45.7 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
7.4 | 29.7 | GO:0002643 | tolerance induction(GO:0002507) regulation of tolerance induction(GO:0002643) |
7.4 | 22.2 | GO:2000360 | positive regulation of female gonad development(GO:2000196) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
7.3 | 72.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
6.9 | 20.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
6.9 | 48.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
6.7 | 26.7 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
6.6 | 19.9 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
6.6 | 39.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
6.5 | 25.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
6.2 | 24.7 | GO:0030242 | pexophagy(GO:0030242) |
6.0 | 18.0 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
5.9 | 76.1 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
5.7 | 5.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
5.7 | 51.4 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
5.7 | 17.1 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
5.6 | 16.8 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
5.5 | 66.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
5.3 | 32.0 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
5.3 | 26.5 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
5.2 | 31.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
5.2 | 41.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
5.1 | 25.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
5.0 | 25.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
5.0 | 15.1 | GO:0006106 | fumarate metabolic process(GO:0006106) L-kynurenine metabolic process(GO:0097052) |
5.0 | 30.1 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
5.0 | 15.0 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
4.8 | 19.0 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
4.7 | 23.7 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
4.7 | 37.7 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
4.6 | 9.3 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
4.6 | 32.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
4.5 | 22.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
4.5 | 31.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
4.5 | 27.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
4.5 | 40.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
4.4 | 17.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
4.4 | 26.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
4.4 | 26.2 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
4.4 | 21.9 | GO:0016036 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
4.3 | 77.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
4.3 | 12.8 | GO:0007518 | myoblast fate determination(GO:0007518) |
4.3 | 12.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
4.2 | 37.9 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
4.2 | 8.3 | GO:0048286 | lung alveolus development(GO:0048286) |
4.1 | 16.5 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
4.1 | 40.7 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
4.0 | 59.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
4.0 | 11.9 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
3.9 | 15.6 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
3.9 | 11.6 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
3.8 | 11.4 | GO:0090135 | actin filament branching(GO:0090135) protein localization to cell leading edge(GO:1902463) |
3.8 | 11.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
3.8 | 26.4 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
3.7 | 41.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
3.7 | 22.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
3.7 | 18.4 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
3.7 | 33.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
3.6 | 10.9 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
3.6 | 10.7 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
3.6 | 10.7 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
3.6 | 21.4 | GO:0051012 | microtubule sliding(GO:0051012) |
3.6 | 10.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
3.5 | 17.7 | GO:0007144 | female meiosis I(GO:0007144) |
3.5 | 35.3 | GO:0042262 | DNA protection(GO:0042262) |
3.4 | 82.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
3.4 | 37.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
3.3 | 10.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
3.3 | 16.7 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
3.3 | 13.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
3.3 | 10.0 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
3.3 | 16.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
3.3 | 23.0 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
3.2 | 19.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
3.2 | 16.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
3.2 | 12.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
3.2 | 12.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
3.2 | 19.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
3.2 | 6.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
3.1 | 15.7 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
3.1 | 21.9 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
3.1 | 12.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.1 | 105.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
3.1 | 43.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
3.1 | 24.7 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
3.1 | 15.4 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
3.1 | 9.2 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
3.0 | 15.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
3.0 | 221.3 | GO:0070126 | mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
3.0 | 9.0 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
3.0 | 33.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
2.9 | 363.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
2.9 | 129.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
2.9 | 14.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
2.9 | 14.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
2.9 | 25.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
2.8 | 2.8 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
2.8 | 8.4 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
2.8 | 11.1 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
2.8 | 24.9 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
2.8 | 27.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
2.8 | 16.5 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
2.7 | 8.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
2.7 | 10.9 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
2.7 | 21.8 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
2.7 | 35.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
2.7 | 21.7 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
2.7 | 16.1 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
2.6 | 7.9 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
2.6 | 23.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
2.6 | 15.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
2.5 | 28.0 | GO:0070986 | left/right axis specification(GO:0070986) |
2.5 | 7.6 | GO:0070295 | renal water absorption(GO:0070295) |
2.5 | 20.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
2.5 | 15.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
2.5 | 7.5 | GO:0006788 | heme oxidation(GO:0006788) |
2.5 | 34.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
2.5 | 2.5 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
2.5 | 19.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
2.5 | 14.9 | GO:1904720 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
2.5 | 7.4 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
2.4 | 7.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
2.4 | 4.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
2.4 | 9.7 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
2.4 | 33.8 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
2.4 | 14.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
2.3 | 16.3 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
2.3 | 9.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
2.3 | 43.7 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
2.3 | 20.3 | GO:0009249 | protein lipoylation(GO:0009249) |
2.2 | 33.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
2.2 | 6.6 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
2.2 | 4.4 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
2.2 | 15.5 | GO:1990539 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
2.2 | 24.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
2.2 | 13.2 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
2.2 | 15.4 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
2.2 | 10.9 | GO:0000720 | meiotic mismatch repair(GO:0000710) pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
2.2 | 6.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
2.2 | 13.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
2.2 | 103.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
2.1 | 10.6 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
2.1 | 14.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.1 | 10.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
2.1 | 16.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
2.1 | 95.8 | GO:0043486 | histone exchange(GO:0043486) |
2.1 | 8.3 | GO:0009956 | radial pattern formation(GO:0009956) |
2.1 | 8.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
2.1 | 10.3 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
2.1 | 53.4 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
2.0 | 28.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
2.0 | 6.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
2.0 | 12.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
2.0 | 11.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
2.0 | 2.0 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
2.0 | 5.9 | GO:1901535 | nephric duct formation(GO:0072179) regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
2.0 | 13.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
2.0 | 11.7 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
2.0 | 41.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.9 | 17.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.9 | 11.5 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.9 | 149.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
1.9 | 9.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.9 | 20.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
1.9 | 5.7 | GO:0052148 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
1.9 | 9.4 | GO:0015862 | uridine transport(GO:0015862) |
1.9 | 13.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.9 | 33.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.9 | 3.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.8 | 7.3 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
1.8 | 5.4 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
1.8 | 7.2 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
1.8 | 12.6 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
1.8 | 19.6 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
1.8 | 3.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
1.8 | 17.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.7 | 10.5 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
1.7 | 8.7 | GO:0003069 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
1.7 | 12.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
1.7 | 10.3 | GO:0015853 | adenine transport(GO:0015853) |
1.7 | 3.4 | GO:1900244 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
1.7 | 13.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.7 | 13.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.7 | 11.7 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.7 | 88.2 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
1.7 | 14.9 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
1.7 | 16.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.6 | 1.6 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
1.6 | 4.9 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
1.6 | 16.4 | GO:0006983 | ER overload response(GO:0006983) |
1.6 | 11.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.6 | 14.5 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.6 | 6.4 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
1.6 | 59.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
1.6 | 76.6 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
1.6 | 8.0 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
1.6 | 9.5 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
1.6 | 98.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
1.6 | 6.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.6 | 10.9 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
1.6 | 6.2 | GO:0021564 | vagus nerve development(GO:0021564) |
1.5 | 24.8 | GO:0000338 | protein deneddylation(GO:0000338) |
1.5 | 9.3 | GO:0006561 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
1.5 | 15.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.5 | 10.7 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
1.5 | 33.5 | GO:0030033 | microvillus assembly(GO:0030033) |
1.5 | 22.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.5 | 12.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.5 | 13.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.5 | 4.5 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
1.5 | 13.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.5 | 28.1 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
1.5 | 29.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
1.5 | 8.8 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
1.5 | 7.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.4 | 99.6 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.4 | 31.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.4 | 2.8 | GO:0051036 | regulation of endosome size(GO:0051036) |
1.4 | 42.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
1.4 | 6.9 | GO:0097102 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
1.4 | 6.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
1.4 | 149.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
1.4 | 5.5 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.4 | 57.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.4 | 20.5 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
1.4 | 5.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.3 | 12.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.3 | 17.2 | GO:0042026 | protein refolding(GO:0042026) |
1.3 | 10.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.3 | 5.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.3 | 5.1 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
1.3 | 6.3 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
1.3 | 22.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
1.2 | 16.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.2 | 18.5 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
1.2 | 3.6 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.2 | 21.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.2 | 120.7 | GO:0006413 | translational initiation(GO:0006413) |
1.2 | 8.3 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
1.2 | 9.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.2 | 16.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.2 | 11.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
1.2 | 13.9 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.2 | 23.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
1.2 | 34.6 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.1 | 1.1 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) facioacoustic ganglion development(GO:1903375) |
1.1 | 6.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.1 | 2.2 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
1.1 | 89.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
1.1 | 2.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.1 | 3.3 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
1.1 | 5.5 | GO:0019228 | neuronal action potential(GO:0019228) |
1.1 | 7.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
1.1 | 7.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.1 | 12.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.1 | 35.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
1.1 | 5.3 | GO:1902739 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
1.0 | 8.4 | GO:0044351 | macropinocytosis(GO:0044351) |
1.0 | 3.1 | GO:0072553 | terminal button organization(GO:0072553) |
1.0 | 8.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
1.0 | 6.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
1.0 | 20.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
1.0 | 8.0 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
1.0 | 1.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
1.0 | 3.0 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
1.0 | 3.0 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
1.0 | 15.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.0 | 4.8 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
1.0 | 3.9 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
1.0 | 5.7 | GO:0032328 | alanine transport(GO:0032328) |
1.0 | 2.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.0 | 4.8 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.9 | 6.6 | GO:0008218 | bioluminescence(GO:0008218) |
0.9 | 5.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.9 | 6.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.9 | 1.9 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.9 | 2.8 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.9 | 4.6 | GO:0045006 | DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
0.9 | 14.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.9 | 8.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.9 | 5.3 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.9 | 20.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.9 | 5.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.9 | 6.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.9 | 29.2 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.9 | 7.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.9 | 10.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.8 | 1.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.8 | 5.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.8 | 0.8 | GO:0045875 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) negative regulation of sister chromatid cohesion(GO:0045875) |
0.8 | 5.7 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.8 | 57.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.8 | 4.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.8 | 11.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.8 | 3.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.8 | 2.3 | GO:2000861 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.8 | 4.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.8 | 7.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.8 | 64.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.8 | 8.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.8 | 19.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.7 | 2.2 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.7 | 10.3 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.7 | 1.4 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.7 | 8.6 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.7 | 2.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.7 | 2.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.7 | 6.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.7 | 2.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.7 | 23.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.7 | 4.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.7 | 0.7 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.7 | 9.2 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.7 | 1.3 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.7 | 9.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.7 | 5.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.7 | 5.9 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.6 | 5.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.6 | 3.2 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.6 | 3.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.6 | 15.1 | GO:0030728 | ovulation(GO:0030728) |
0.6 | 7.5 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.6 | 10.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 11.8 | GO:0014904 | myotube cell development(GO:0014904) |
0.6 | 32.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.6 | 4.9 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.6 | 17.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.6 | 6.6 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.6 | 1.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.6 | 4.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 4.8 | GO:0002934 | desmosome organization(GO:0002934) |
0.6 | 1.8 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.6 | 4.8 | GO:0002326 | B cell lineage commitment(GO:0002326) immunoglobulin V(D)J recombination(GO:0033152) |
0.6 | 8.8 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.6 | 3.5 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.6 | 2.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.6 | 12.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.6 | 30.4 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.6 | 26.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.6 | 4.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.6 | 2.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.6 | 14.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.6 | 4.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.6 | 3.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.6 | 3.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 6.0 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.5 | 1.6 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.5 | 20.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.5 | 3.7 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.5 | 3.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.5 | 1.6 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.5 | 9.9 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.5 | 11.4 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.5 | 1.0 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.5 | 3.1 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.5 | 7.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.5 | 2.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 2.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.5 | 2.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.5 | 8.9 | GO:0001825 | blastocyst formation(GO:0001825) |
0.5 | 2.0 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.5 | 1.5 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.5 | 22.4 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.5 | 1.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 27.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 4.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.5 | 0.9 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.5 | 1.4 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.5 | 1.4 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.5 | 4.7 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.5 | 1.4 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.5 | 18.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.5 | 7.3 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.4 | 24.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.4 | 1.8 | GO:0090656 | t-circle formation(GO:0090656) |
0.4 | 3.1 | GO:0015816 | glycine transport(GO:0015816) |
0.4 | 23.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.4 | 5.8 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 2.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 5.0 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.4 | 0.8 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.4 | 6.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.4 | 9.3 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.4 | 9.7 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.4 | 8.5 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.4 | 19.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.4 | 2.8 | GO:0016559 | peroxisome fission(GO:0016559) |
0.4 | 3.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.4 | 4.6 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.4 | 7.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.4 | 1.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.4 | 1.8 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.4 | 0.7 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.4 | 11.0 | GO:0033198 | response to ATP(GO:0033198) |
0.4 | 4.9 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 4.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.3 | 4.7 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.3 | 2.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.3 | 3.3 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.3 | 3.3 | GO:0051348 | negative regulation of transferase activity(GO:0051348) |
0.3 | 7.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 25.8 | GO:0045333 | cellular respiration(GO:0045333) |
0.3 | 2.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.3 | 1.6 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.3 | 2.8 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 1.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.3 | 3.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 3.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 3.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 1.4 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.3 | 2.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 1.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 9.5 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.3 | 3.8 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.3 | 4.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 4.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 1.0 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.3 | 0.8 | GO:0030578 | PML body organization(GO:0030578) |
0.3 | 17.4 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.3 | 3.1 | GO:0010458 | exit from mitosis(GO:0010458) |
0.3 | 1.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 13.3 | GO:0016575 | histone deacetylation(GO:0016575) |
0.3 | 2.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 6.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 7.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 46.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.2 | GO:0051387 | negative regulation of icosanoid secretion(GO:0032304) negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) negative regulation of fatty acid transport(GO:2000192) |
0.2 | 11.0 | GO:0032418 | lysosome localization(GO:0032418) |
0.2 | 4.2 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 3.9 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.9 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) maintenance of DNA repeat elements(GO:0043570) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 1.5 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.2 | 2.1 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.2 | 0.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.2 | 12.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 4.2 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.2 | 3.4 | GO:0019184 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
0.2 | 0.4 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.2 | 1.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.2 | 1.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 2.5 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 0.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.2 | 1.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 2.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 3.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 3.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 6.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 1.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.6 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 3.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 4.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.9 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 0.9 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.2 | 4.7 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.1 | 0.9 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 6.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.8 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 1.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.8 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.8 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.9 | GO:0045927 | positive regulation of growth(GO:0045927) |
0.1 | 2.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 3.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 2.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 2.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 4.6 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.1 | 0.2 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.1 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 6.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 1.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.8 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 1.3 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 0.4 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.1 | 1.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 1.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.8 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.1 | 3.9 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.7 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.2 | GO:0032771 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.1 | 0.3 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.0 | 1.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 1.7 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 1.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 2.4 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
0.0 | 2.7 | GO:0060606 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.0 | 2.4 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 0.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.9 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.6 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
0.0 | 0.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.8 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 1.2 | GO:0050871 | positive regulation of B cell activation(GO:0050871) |
0.0 | 0.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.0 | 66.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
13.0 | 104.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
11.9 | 59.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
10.4 | 104.2 | GO:0000243 | commitment complex(GO:0000243) |
10.4 | 51.8 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
9.5 | 57.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
9.3 | 37.3 | GO:0055087 | Ski complex(GO:0055087) |
9.0 | 36.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
8.9 | 44.7 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
8.8 | 61.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
8.7 | 26.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
8.3 | 24.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
8.2 | 24.7 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
7.9 | 39.6 | GO:0033503 | HULC complex(GO:0033503) |
7.9 | 39.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
7.7 | 23.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
7.7 | 23.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
7.7 | 84.2 | GO:0005688 | U6 snRNP(GO:0005688) |
7.6 | 22.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
7.4 | 22.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
7.4 | 29.5 | GO:1990423 | RZZ complex(GO:1990423) |
7.2 | 28.6 | GO:0031417 | NatC complex(GO:0031417) |
7.0 | 91.5 | GO:0042555 | MCM complex(GO:0042555) |
6.8 | 20.5 | GO:0032302 | MutSbeta complex(GO:0032302) |
6.4 | 25.7 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
6.3 | 101.1 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
6.2 | 37.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
6.1 | 102.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
5.9 | 76.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
5.4 | 42.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
5.3 | 5.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
5.3 | 21.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
5.2 | 26.2 | GO:0097125 | condensed nuclear chromosome outer kinetochore(GO:0000942) cyclin B1-CDK1 complex(GO:0097125) |
5.1 | 5.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
5.1 | 25.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
5.0 | 25.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
5.0 | 35.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
5.0 | 39.9 | GO:0005687 | U4 snRNP(GO:0005687) |
4.9 | 24.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
4.9 | 133.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
4.9 | 24.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
4.8 | 100.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
4.7 | 18.9 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
4.4 | 13.2 | GO:0097441 | basilar dendrite(GO:0097441) |
4.4 | 82.7 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
4.3 | 89.3 | GO:0000812 | Swr1 complex(GO:0000812) |
4.2 | 80.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
4.2 | 33.4 | GO:0070552 | BRISC complex(GO:0070552) |
4.2 | 12.5 | GO:0044393 | microspike(GO:0044393) |
4.1 | 24.8 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
4.1 | 57.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
4.0 | 36.2 | GO:0005827 | polar microtubule(GO:0005827) |
3.9 | 11.6 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
3.8 | 76.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
3.8 | 34.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
3.8 | 56.6 | GO:0090543 | Flemming body(GO:0090543) |
3.7 | 18.7 | GO:0001940 | male pronucleus(GO:0001940) |
3.7 | 18.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
3.7 | 25.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
3.6 | 25.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
3.6 | 32.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
3.4 | 20.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
3.4 | 13.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
3.4 | 102.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
3.4 | 41.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
3.4 | 33.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
3.3 | 39.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
3.3 | 29.7 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
3.3 | 36.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
3.3 | 23.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
3.3 | 9.8 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
3.2 | 16.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
3.2 | 154.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
3.1 | 12.4 | GO:0005839 | proteasome core complex(GO:0005839) |
3.1 | 59.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
3.1 | 21.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
3.1 | 9.2 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
2.9 | 20.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
2.9 | 75.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
2.9 | 8.7 | GO:0072563 | endothelial microparticle(GO:0072563) |
2.9 | 20.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
2.7 | 40.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
2.7 | 32.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.6 | 7.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.5 | 56.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
2.5 | 10.1 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
2.5 | 34.9 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
2.5 | 17.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
2.4 | 9.7 | GO:0000799 | nuclear condensin complex(GO:0000799) |
2.4 | 46.1 | GO:0036020 | endolysosome membrane(GO:0036020) |
2.4 | 12.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
2.4 | 30.7 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
2.3 | 16.1 | GO:0070852 | cell body fiber(GO:0070852) |
2.3 | 6.9 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
2.3 | 149.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
2.2 | 94.4 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
2.2 | 15.7 | GO:0071203 | WASH complex(GO:0071203) |
2.2 | 6.6 | GO:0031523 | Myb complex(GO:0031523) |
2.2 | 239.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
2.1 | 26.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.0 | 10.2 | GO:0044308 | axonal spine(GO:0044308) |
2.0 | 13.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
2.0 | 13.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
1.9 | 7.7 | GO:0030891 | VCB complex(GO:0030891) |
1.9 | 24.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
1.9 | 26.2 | GO:0031932 | TORC2 complex(GO:0031932) |
1.9 | 5.6 | GO:0031415 | N-terminal protein acetyltransferase complex(GO:0031414) NatA complex(GO:0031415) |
1.9 | 57.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.8 | 29.3 | GO:0036452 | ESCRT complex(GO:0036452) |
1.8 | 16.4 | GO:0061574 | ASAP complex(GO:0061574) |
1.8 | 41.7 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
1.8 | 18.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
1.7 | 12.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.7 | 306.4 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
1.7 | 11.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.6 | 4.9 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
1.6 | 6.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.6 | 11.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.6 | 20.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.5 | 262.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
1.5 | 10.5 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
1.5 | 4.5 | GO:0016939 | kinesin II complex(GO:0016939) |
1.5 | 7.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.4 | 12.8 | GO:0005869 | dynactin complex(GO:0005869) |
1.4 | 16.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.4 | 19.1 | GO:0001891 | phagocytic cup(GO:0001891) |
1.3 | 36.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.3 | 10.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
1.3 | 6.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.3 | 11.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.2 | 5.0 | GO:0005685 | U1 snRNP(GO:0005685) |
1.2 | 3.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.2 | 16.3 | GO:0016580 | Sin3 complex(GO:0016580) |
1.1 | 25.1 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
1.1 | 24.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.1 | 8.7 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
1.1 | 7.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.1 | 8.6 | GO:0000322 | storage vacuole(GO:0000322) |
1.1 | 74.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
1.0 | 5.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.0 | 26.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.0 | 8.3 | GO:0030478 | actin cap(GO:0030478) |
1.0 | 23.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
1.0 | 17.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.0 | 3.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
1.0 | 23.2 | GO:0005876 | spindle microtubule(GO:0005876) |
1.0 | 5.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.9 | 10.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.9 | 23.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.9 | 75.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.9 | 10.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.9 | 8.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.8 | 3.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.8 | 3.3 | GO:0032044 | DSIF complex(GO:0032044) |
0.8 | 2.5 | GO:0031213 | RSF complex(GO:0031213) |
0.8 | 6.5 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.8 | 27.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.8 | 5.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.8 | 8.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 7.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.8 | 6.9 | GO:0097443 | sorting endosome(GO:0097443) |
0.8 | 8.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.8 | 42.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.7 | 11.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.7 | 22.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.7 | 40.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.7 | 12.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.7 | 53.3 | GO:0000922 | spindle pole(GO:0000922) |
0.7 | 5.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.7 | 2.8 | GO:0035061 | Smc5-Smc6 complex(GO:0030915) interchromatin granule(GO:0035061) |
0.7 | 45.5 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.7 | 28.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.7 | 4.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.7 | 7.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.7 | 2.0 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.7 | 3.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.6 | 14.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.6 | 29.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.6 | 1.1 | GO:0030425 | dendrite(GO:0030425) |
0.5 | 7.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.5 | 16.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.5 | 5.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 2.0 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.5 | 22.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.5 | 38.2 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.5 | 6.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.5 | 7.0 | GO:0097346 | INO80-type complex(GO:0097346) |
0.5 | 8.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.5 | 16.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.5 | 5.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 5.4 | GO:0032420 | stereocilium(GO:0032420) |
0.4 | 5.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 27.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.4 | 5.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 20.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 1.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 8.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 13.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.4 | 19.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 3.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 15.6 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.3 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.3 | 25.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 1.0 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.3 | 34.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 22.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 40.5 | GO:0016605 | PML body(GO:0016605) |
0.3 | 11.5 | GO:0002102 | podosome(GO:0002102) |
0.3 | 26.8 | GO:0030496 | midbody(GO:0030496) |
0.3 | 2.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 0.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.3 | 14.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 2.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 87.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 4.5 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 9.6 | GO:0005840 | ribosome(GO:0005840) |
0.3 | 32.5 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 7.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 4.7 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 9.6 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 5.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 0.8 | GO:0097361 | CIA complex(GO:0097361) |
0.3 | 1.9 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 20.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 11.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 17.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 1.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 23.7 | GO:0035579 | specific granule membrane(GO:0035579) |
0.2 | 1.8 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 2.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 3.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 6.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 8.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 5.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 6.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 8.8 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 67.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 2.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 11.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 6.0 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 4.3 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.2 | 0.9 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 0.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 4.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 1.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 1.4 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 35.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 3.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 6.1 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 1.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 3.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 3.9 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 1.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 19.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 2.8 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 1.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 2.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 3.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 1.7 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.0 | 0.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.4 | GO:0031904 | endosome lumen(GO:0031904) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.3 | 87.8 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
29.2 | 87.5 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
20.1 | 120.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
12.5 | 87.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
10.5 | 31.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
9.9 | 39.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
9.6 | 67.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
8.8 | 87.8 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
8.7 | 43.5 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
8.4 | 33.8 | GO:0031208 | POZ domain binding(GO:0031208) |
8.3 | 49.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
8.3 | 66.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
7.9 | 23.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
7.5 | 22.6 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
7.4 | 22.3 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
7.2 | 21.7 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
7.2 | 43.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
6.9 | 20.6 | GO:0004766 | spermidine synthase activity(GO:0004766) |
6.6 | 53.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
6.5 | 19.6 | GO:0000035 | acyl binding(GO:0000035) phosphopantetheine binding(GO:0031177) |
6.0 | 36.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
6.0 | 23.9 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
5.6 | 16.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
5.6 | 5.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
5.6 | 27.9 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
5.4 | 59.8 | GO:0015266 | protein channel activity(GO:0015266) |
5.3 | 26.3 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
5.2 | 41.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
5.2 | 51.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
5.2 | 15.5 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
5.1 | 15.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
5.0 | 15.1 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
5.0 | 34.9 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
5.0 | 14.9 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
4.9 | 102.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
4.8 | 38.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
4.8 | 19.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
4.8 | 14.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
4.8 | 38.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
4.8 | 19.1 | GO:0043515 | kinetochore binding(GO:0043515) |
4.7 | 141.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
4.7 | 28.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
4.4 | 13.1 | GO:0032089 | NACHT domain binding(GO:0032089) |
4.3 | 29.9 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
4.2 | 29.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
4.2 | 16.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
4.2 | 12.5 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
4.0 | 20.2 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
4.0 | 16.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
4.0 | 8.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
4.0 | 67.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
4.0 | 39.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
3.9 | 31.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
3.9 | 11.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
3.8 | 76.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
3.8 | 30.4 | GO:0019863 | IgE binding(GO:0019863) |
3.8 | 15.1 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
3.7 | 26.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
3.7 | 15.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
3.7 | 11.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
3.6 | 21.9 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
3.6 | 40.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
3.6 | 14.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
3.6 | 10.7 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
3.5 | 14.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
3.5 | 21.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
3.5 | 31.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
3.5 | 10.5 | GO:0032427 | GBD domain binding(GO:0032427) |
3.2 | 16.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
3.2 | 16.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
3.2 | 12.9 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
3.1 | 22.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
3.1 | 53.1 | GO:0008494 | translation activator activity(GO:0008494) |
3.1 | 21.9 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
3.1 | 37.0 | GO:0050700 | CARD domain binding(GO:0050700) |
3.0 | 14.9 | GO:0050436 | microfibril binding(GO:0050436) |
3.0 | 41.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
2.9 | 54.7 | GO:0051400 | BH domain binding(GO:0051400) |
2.8 | 31.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
2.8 | 8.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
2.8 | 25.1 | GO:0032190 | acrosin binding(GO:0032190) |
2.8 | 8.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
2.7 | 52.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
2.7 | 8.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
2.7 | 21.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.7 | 48.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
2.7 | 16.1 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
2.7 | 13.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
2.6 | 76.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
2.6 | 20.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
2.6 | 26.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
2.5 | 7.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.5 | 22.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
2.5 | 7.5 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
2.5 | 7.5 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
2.5 | 14.9 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
2.5 | 12.4 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
2.4 | 33.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.4 | 43.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
2.4 | 9.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
2.3 | 32.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
2.3 | 9.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
2.3 | 20.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
2.3 | 9.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.3 | 50.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.3 | 9.1 | GO:0036033 | mediator complex binding(GO:0036033) |
2.3 | 11.4 | GO:0070728 | leucine binding(GO:0070728) |
2.3 | 15.9 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
2.2 | 15.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
2.2 | 87.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
2.2 | 8.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
2.2 | 4.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
2.2 | 15.5 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
2.2 | 15.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.2 | 8.8 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
2.2 | 13.2 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
2.2 | 15.4 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
2.1 | 76.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
2.1 | 450.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
2.1 | 73.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
2.0 | 4.1 | GO:0017040 | ceramidase activity(GO:0017040) |
2.0 | 21.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.0 | 53.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.9 | 17.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.9 | 5.8 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
1.9 | 7.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.9 | 5.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.9 | 5.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.9 | 7.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.9 | 124.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
1.8 | 12.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.8 | 5.4 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
1.8 | 5.4 | GO:0015106 | sodium:bicarbonate symporter activity(GO:0008510) bicarbonate transmembrane transporter activity(GO:0015106) |
1.8 | 95.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
1.7 | 20.2 | GO:0003713 | transcription coactivator activity(GO:0003713) |
1.6 | 34.3 | GO:0070628 | proteasome binding(GO:0070628) |
1.6 | 6.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.6 | 4.9 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
1.6 | 28.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.6 | 8.0 | GO:0016403 | dimethylargininase activity(GO:0016403) |
1.6 | 11.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
1.6 | 6.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
1.6 | 7.9 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
1.6 | 18.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.6 | 4.7 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
1.5 | 74.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
1.5 | 18.5 | GO:0031386 | protein tag(GO:0031386) |
1.5 | 9.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.5 | 10.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.5 | 16.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
1.5 | 28.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.5 | 16.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.5 | 43.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.4 | 14.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
1.4 | 63.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.4 | 61.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
1.4 | 5.6 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
1.4 | 80.5 | GO:0019894 | kinesin binding(GO:0019894) |
1.4 | 143.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.4 | 15.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.3 | 37.7 | GO:0070717 | poly-purine tract binding(GO:0070717) |
1.3 | 35.8 | GO:0070840 | dynein complex binding(GO:0070840) |
1.3 | 10.5 | GO:1990763 | arrestin family protein binding(GO:1990763) |
1.3 | 26.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
1.3 | 10.3 | GO:0015288 | porin activity(GO:0015288) |
1.3 | 32.0 | GO:0031489 | myosin V binding(GO:0031489) |
1.3 | 6.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
1.3 | 6.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.2 | 7.5 | GO:1990254 | keratin filament binding(GO:1990254) |
1.2 | 28.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
1.2 | 14.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.2 | 3.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.2 | 3.6 | GO:0019239 | deaminase activity(GO:0019239) |
1.2 | 3.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.2 | 11.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.2 | 5.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.2 | 5.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.2 | 8.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.2 | 22.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.1 | 11.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.1 | 5.7 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
1.1 | 3.4 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
1.1 | 13.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.1 | 2.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
1.1 | 6.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.1 | 3.2 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
1.1 | 11.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.1 | 4.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
1.1 | 3.2 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
1.0 | 15.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
1.0 | 8.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.0 | 79.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
1.0 | 6.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
1.0 | 6.1 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
1.0 | 7.0 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
1.0 | 7.0 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
1.0 | 11.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.0 | 3.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.0 | 12.9 | GO:0008252 | nucleotidase activity(GO:0008252) |
1.0 | 10.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
1.0 | 6.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.0 | 8.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.0 | 2.9 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
1.0 | 11.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.9 | 1.9 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.9 | 16.0 | GO:0017069 | snRNA binding(GO:0017069) |
0.9 | 5.6 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.9 | 4.7 | GO:0001849 | complement component C1q binding(GO:0001849) choline binding(GO:0033265) |
0.9 | 8.3 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.9 | 12.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.9 | 10.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.9 | 7.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.9 | 12.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.9 | 29.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.9 | 24.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.9 | 5.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.8 | 12.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 6.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.8 | 33.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.8 | 17.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.8 | 18.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.8 | 4.0 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.8 | 3.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.8 | 14.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.8 | 18.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.7 | 3.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.7 | 11.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.7 | 17.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.7 | 8.0 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) decanoate--CoA ligase activity(GO:0102391) |
0.7 | 16.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.7 | 38.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.7 | 20.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 5.5 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.7 | 123.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.7 | 15.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.7 | 14.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.7 | 2.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.7 | 3.3 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.6 | 4.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.6 | 7.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.6 | 8.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.6 | 14.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.6 | 16.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 1.3 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.6 | 39.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.6 | 20.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 8.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.6 | 138.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.6 | 56.5 | GO:0042393 | histone binding(GO:0042393) |
0.6 | 2.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 34.9 | GO:0019003 | GDP binding(GO:0019003) |
0.6 | 1.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.6 | 1.7 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.6 | 5.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 6.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 11.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 13.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.5 | 10.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 10.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.5 | 13.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 18.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.5 | 1.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.5 | 3.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.5 | 2.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 5.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 3.0 | GO:0039552 | RIG-I binding(GO:0039552) |
0.5 | 4.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.5 | 38.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.5 | 6.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 1.4 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.5 | 2.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 9.9 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.4 | 2.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.4 | 36.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.4 | 19.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.4 | 9.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 26.4 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.4 | 17.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.4 | 5.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 73.5 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.4 | 1.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 4.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.4 | 2.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 1.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.4 | 22.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.4 | 15.7 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.4 | 125.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.4 | 4.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.4 | 8.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.4 | 1.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 9.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 3.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 5.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 3.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 9.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.3 | 7.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 2.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 1.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.3 | 0.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.3 | 5.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 6.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 10.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 1.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 23.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 257.7 | GO:0003723 | RNA binding(GO:0003723) |
0.3 | 54.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.3 | 9.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 1.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.3 | 3.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 1.4 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 2.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 3.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 14.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 1.3 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 0.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 3.8 | GO:0015923 | mannosidase activity(GO:0015923) |
0.2 | 2.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.6 | GO:0005254 | chloride channel activity(GO:0005254) |
0.2 | 2.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 2.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 3.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 0.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 0.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.9 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.2 | 2.4 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 3.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 0.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 1.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 12.0 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
0.1 | 3.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 3.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.8 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.3 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.1 | 29.3 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.5 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 1.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 1.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 1.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.7 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 2.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 1.5 | GO:0015085 | calcium channel activity(GO:0005262) calcium ion transmembrane transporter activity(GO:0015085) |
0.0 | 0.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 1.2 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 1.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.4 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.0 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.0 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 1.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 34.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
3.1 | 102.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
2.8 | 123.6 | PID BARD1 PATHWAY | BARD1 signaling events |
2.7 | 5.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.7 | 100.7 | PID AURORA A PATHWAY | Aurora A signaling |
2.7 | 179.3 | PID ATR PATHWAY | ATR signaling pathway |
2.1 | 129.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
2.1 | 128.1 | PID AURORA B PATHWAY | Aurora B signaling |
1.4 | 46.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.2 | 44.3 | PID PLK1 PATHWAY | PLK1 signaling events |
1.2 | 12.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.1 | 3.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.1 | 25.7 | PID ARF 3PATHWAY | Arf1 pathway |
1.1 | 58.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.1 | 20.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.1 | 36.3 | PID MYC PATHWAY | C-MYC pathway |
1.1 | 57.5 | PID P53 REGULATION PATHWAY | p53 pathway |
1.1 | 51.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.1 | 63.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.0 | 28.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.0 | 61.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.0 | 85.3 | PID E2F PATHWAY | E2F transcription factor network |
1.0 | 23.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.0 | 46.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.9 | 17.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.9 | 32.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.9 | 45.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.8 | 76.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.8 | 14.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.8 | 39.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.8 | 7.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.8 | 16.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.7 | 46.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.7 | 11.9 | PID ATM PATHWAY | ATM pathway |
0.6 | 16.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 12.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.6 | 10.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.5 | 29.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.5 | 8.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 5.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 5.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 5.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 11.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 9.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.4 | 29.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 3.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 4.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 3.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 5.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 14.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 9.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 6.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 29.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 4.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 4.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 5.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 3.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 3.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 2.7 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 2.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.0 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 3.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 3.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 1.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.4 | 193.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
6.6 | 105.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
4.9 | 73.5 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
4.3 | 102.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
4.0 | 102.8 | REACTOME KINESINS | Genes involved in Kinesins |
3.8 | 57.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
3.8 | 60.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
3.8 | 127.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
3.7 | 48.6 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
3.6 | 72.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
3.6 | 97.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
3.5 | 358.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
2.9 | 104.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
2.8 | 28.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
2.8 | 25.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.8 | 53.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
2.5 | 58.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
2.5 | 7.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
2.5 | 413.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
2.5 | 102.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
2.5 | 81.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
2.4 | 49.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
2.3 | 91.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
2.3 | 100.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
2.3 | 32.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
2.3 | 13.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
2.3 | 50.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
2.2 | 78.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
2.2 | 39.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
2.1 | 54.7 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
2.1 | 188.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
2.0 | 24.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
2.0 | 56.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.9 | 3.8 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
1.9 | 49.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
1.9 | 11.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.8 | 35.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.7 | 26.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
1.6 | 9.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.6 | 15.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.6 | 123.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.6 | 51.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.5 | 83.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.5 | 47.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.5 | 29.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
1.4 | 26.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.3 | 37.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.3 | 29.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.3 | 30.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
1.2 | 39.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.2 | 19.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.2 | 47.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.2 | 8.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
1.2 | 44.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.1 | 12.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.1 | 17.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.1 | 26.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.1 | 5.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.1 | 25.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.0 | 18.8 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
1.0 | 165.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.0 | 24.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.9 | 6.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.9 | 12.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.9 | 31.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.9 | 17.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.9 | 15.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.9 | 18.4 | REACTOME S PHASE | Genes involved in S Phase |
0.9 | 17.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.9 | 3.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.9 | 22.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.8 | 9.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.8 | 91.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.8 | 5.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.8 | 22.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 20.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.7 | 9.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.7 | 9.6 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.7 | 34.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.7 | 27.7 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.6 | 7.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.6 | 10.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.6 | 20.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 32.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.6 | 10.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 13.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.6 | 9.8 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.6 | 8.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 6.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 26.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 12.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 12.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 4.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.5 | 22.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.5 | 8.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 17.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 37.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 9.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 7.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 9.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 6.7 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.4 | 22.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 15.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.4 | 23.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.4 | 9.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 4.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 8.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 5.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 6.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 7.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 5.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 5.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 2.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 18.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 9.7 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.3 | 3.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 13.9 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.2 | 2.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 2.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 3.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.8 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 10.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 2.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 3.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 4.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 8.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 7.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 3.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 8.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 5.4 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 6.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 8.4 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 2.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 8.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 1.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.5 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 0.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |